ConductScience.org, home

Paper25257573

Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.

Anderson JL and 4 others. AIDS Res Hum Retroviruses, 2015. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium. Papers, record 25257573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25257573

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.
PubMed
Journal
AIDS Res Hum Retroviruses
PubMed
Year
2015
PubMed
Publication types
Conference Proceedings, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.6
iCite
Revised in PubMed
2026-01-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Anderson JLJenny Louise
2Fromentin RRémi
3Corbelli GMGiulio Maria
4Østergaard LLars
5Ross ALAnna Laura

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS VaccinesMajor topic
Acquired Immunodeficiency SyndromeMajor topic
Anti-HIV AgentsMajor topic
CD4-Positive T-LymphocytesMajor topic
CD8-Positive T-LymphocytesMajor topic
Antiretroviral Therapy, Highly Active
Biomedical Research
Enzyme Activation
Humans
NF-kappa B
Positive Transcriptional Elongation Factor B
Treatment Outcome
Virus Latency

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122802445BET bromodomain inhibition as a novel strategy for reactivation of HIV-1.J Leukoc Biol2012https://conductscience.org/library/papers/22802445PubMed
225071766Baseline and Dynamic Expression of Activating NK Cell Receptors in the Control of Chronic Viral Infections: The Paradigm of HIV-1 and HCV.Front Immunol2014https://conductscience.org/library/papers/25071766PubMed
326423811Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial.Lancet HIV2014https://conductscience.org/library/papers/26423811PubMed
423255218BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.Cell Cycle2013https://conductscience.org/library/papers/23255218PubMed
524990883Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor.Sci Transl Med2014https://conductscience.org/library/papers/24990883PubMed
624339779Myeloid dendritic cells induce HIV-1 latency in non-proliferating CD4+ T cells.PLoS Pathog2013https://conductscience.org/library/papers/24339779PubMed
722837004Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.Nature2012https://conductscience.org/library/papers/22837004PubMed
824804860Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cδ-NF-κB signaling.AIDS2014https://conductscience.org/library/papers/24804860PubMed
924620025HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.J Infect Dis2014https://conductscience.org/library/papers/24620025PubMed
1023460751Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation.J Infect Dis2013https://conductscience.org/library/papers/23460751PubMed
1116289657The gammac-cytokine regulated transcription factor, STAT5, increases HIV-1 production in primary CD4 T cells.Virology2006https://conductscience.org/library/papers/16289657PubMed
1220616233Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.Science2010https://conductscience.org/library/papers/20616233PubMed
1325013066A critical question for HIV vaccine development: which antibodies to induce?Science2014https://conductscience.org/library/papers/25013066PubMed
1424336828A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy.Clin Infect Dis2014https://conductscience.org/library/papers/24336828PubMed
1524827152Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.PLoS One2014https://conductscience.org/library/papers/24827152PubMed
1624025770Immune clearance of highly pathogenic SIV infection.Nature2013https://conductscience.org/library/papers/24025770PubMed
1724152233Absence of detectable HIV-1 viremia after treatment cessation in an infant.N Engl J Med2013https://conductscience.org/library/papers/24152233PubMed
1824965460Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.J Virol2014https://conductscience.org/library/papers/24965460PubMed
1925038345An HIV cure: feasibility, discovery, and implementation.JAMA2014https://conductscience.org/library/papers/25038345PubMed
2024722454Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing.PLoS Pathog2014https://conductscience.org/library/papers/24722454PubMed

See all 35 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
35297660Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX-a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine.J Virol2022https://conductscience.org/library/papers/35297660PubMed
32764508Antiretroviral Therapy Interruption (ATI) in HIV-1 Infected Patients Participating in Therapeutic Vaccine Trials: Surrogate Markers of Virological Response.Vaccines (Basel)2020https://conductscience.org/library/papers/32764508PubMed
32435247HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02).Front Immunol2020https://conductscience.org/library/papers/32435247PubMed
32128329Virological Outcome Measures During Analytical Treatment Interruptions in Chronic HIV-1-Infected Patients.Open Forum Infect Dis2019https://conductscience.org/library/papers/32128329PubMed
31941478Crowdsourcing contests to facilitate community engagement in HIV cure research: a qualitative evaluation of facilitators and barriers of participation.BMC Public Health2020https://conductscience.org/library/papers/31941478PubMed
31312806Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study).EClinicalMedicine2019https://conductscience.org/library/papers/31312806PubMed
30142171Perceptions of HIV cure research among people living with HIV in Australia.PLoS One2018https://conductscience.org/library/papers/30142171PubMed
29141633Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.Retrovirology2017https://conductscience.org/library/papers/29141633PubMed
28953921Virological and immunological outcome of treatment interruption in HIV-1-infected subjects vaccinated with MVA-B.PLoS One2017https://conductscience.org/library/papers/28953921PubMed
27781107The latest science from the IAS Towards an HIV Cure Symposium: 16-17 July 2016, Durban, South Africa.J Virus Erad2016https://conductscience.org/library/papers/27781107PubMed
27402887The social value of candidate HIV cures: actualism versus possibilism.J Med Ethics2017https://conductscience.org/library/papers/27402887PubMed
27259546When to start paediatric testing of the adult HIV cure research agenda?J Med Ethics2017https://conductscience.org/library/papers/27259546PubMed
26933962Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?PLoS Biol2016https://conductscience.org/library/papers/26933962PubMed
26907881Global strategies are required to cure and eliminate HBV infection.Nat Rev Gastroenterol Hepatol2016https://conductscience.org/library/papers/26907881PubMed
26561337Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions.J Int AIDS Soc2015https://conductscience.org/library/papers/26561337PubMed
25835530Eradication of HIV-1 from the macrophage reservoir: an uncertain goal?Viruses2015https://conductscience.org/library/papers/25835530PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25257573

GET https://conductscience.org/api/papers/v1/25257573/references?page=2